NLS

Dr. Joanna Rorbach, principal researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet, has been awarded the prestigious Göran Gustafsson Prize by the Royal Swedish Academy of Sciences (Kungliga Vetenskapsakademien).

In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.

Nasal drug delivery is a dynamic area in pharmaceutical innovation. What was once a route for decongestants and allergy sprays is now being explored for everything from emergency treatments to vaccines – and even shows potential for future central nervous system therapies.

In a nation that’s historically strong in tech, Finnish pharmaceutical development still struggles to capture the imagination of investors. The Finnish Drug Discovery Center sets out to help early-stage life science companies take their first steps towards investments and clinical development.

When Cancer Crosslinks took place in Oslo on January 22, it marked the meeting’s 18th anniversary. It’s “really coming of age,” jokes Jutta Heix, the Head of International Affairs at Oslo Cancer Cluster, which organizes the meeting.

As global tensions rise and the United States moves in a more unpredictable direction, Europe’s life science sector is under pressure to strengthen its competitiveness. According to Medicon Valley Alliance's (MVA) CEO, Anette Steenberg, the Nordics have a decisive role to play – but only if the region can act as one.